Cargando…

Characteristics of Tau and Its Ligands in PET Imaging

Tau deposition is one of the neuropathological hallmarks in Alzheimer’s disease as well as in other neurodegenerative disorders called tauopathies. Recent efforts to develop selective tau radiopharmaceuticals have allowed the visualization of tau deposits in vivo. In vivo tau imaging allows the asse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harada, Ryuichi, Okamura, Nobuyuki, Furumoto, Shozo, Tago, Tetsuro, Yanai, Kazuhiko, Arai, Hiroyuki, Kudo, Yukitsuka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808801/ https://www.ncbi.nlm.nih.gov/pubmed/26751494 http://dx.doi.org/10.3390/biom6010007

Ejemplares similares

Imaging of Reactive Astrogliosis by Positron Emission Tomography
por: Harada, Ryuichi, et al.
Publicado: (2022)

Imaging Protein Misfolding in the Brain Using β-Sheet Ligands
por: Harada, Ryuichi, et al.
Publicado: (2018)

Corrigendum: Imaging Protein Misfolding in the Brain Using β-Sheet Ligands
por: Harada, Ryuichi, et al.
Publicado: (2018)

Longitudinal Assessment of Tau Pathology in Patients with Alzheimer’s Disease Using [(18)F]THK-5117 Positron Emission Tomography
por: Ishiki, Aiko, et al.
Publicado: (2015)

Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer’s Disease Patients Measured Using [18F] THK-5351
por: Lockhart, Samuel N., et al.
Publicado: (2016)

Evaluation of (18)F labeled glial fibrillary acidic protein binding nanobody and its brain shuttle peptide fusion proteins using a neuroinflammation rat model
por: Morito, Takahiro, et al.
Publicado: (2023)

The development and validation of tau PET tracers: current status and future directions
por: Okamura, Nobuyuki, et al.
Publicado: (2018)

PT572. Advances in the Development of Tau PET Radiotracers and Their Clinical Applications
por: Yanai, Kazuhiko, et al.
Publicado: (2016)

Assessing THK523 selectivity for tau deposits in Alzheimer’s disease and non–Alzheimer’s disease tauopathies
por: Fodero-Tavoletti, Michelle T, et al.
Publicado: (2014)

Evaluation of the biodistribution and radiation dosimetry of the (18)F-labelled amyloid imaging probe [(18)F]FACT in humans
por: Shidahara, Miho, et al.
Publicado: (2013)

Neuroimaging-pathological correlations of [(18)F]THK5351 PET in progressive supranuclear palsy
por: Ishiki, Aiko, et al.
Publicado: (2018)

Synthesis and pharmacokinetic characterisation of a fluorine-18 labelled brain shuttle peptide fusion dimeric affibody
por: Morito, Takahiro, et al.
Publicado: (2021)

Regional tau deposition and subregion atrophy of medial temporal structures in early Alzheimer's disease: A combined positron emission tomography/magnetic resonance imaging study
por: Sone, Daichi, et al.
Publicado: (2017)

Dissociation of Tau Deposits and Brain Atrophy in Early Alzheimer’s Disease: A Combined Positron Emission Tomography/Magnetic Resonance Imaging Study
por: Shigemoto, Yoko, et al.
Publicado: (2018)

Association of deposition of tau and amyloid‐β proteins with structural connectivity changes in cognitively normal older adults and Alzheimer’s disease spectrum patients
por: Shigemoto, Yoko, et al.
Publicado: (2018)

(18)F-THK5351 Positron Emission Tomography Imaging in Neurodegenerative Tauopathies
por: Ezura, Michinori, et al.
Publicado: (2021)

Advances in the Development of PET Ligands Targeting Histone Deacetylases for the Assessment of Neurodegenerative Diseases
por: Tago, Tetsuro, et al.
Publicado: (2018)

Untangling tau imaging
por: Villemagne, Victor L., et al.
Publicado: (2016)

Topographical Heterogeneity of Alzheimer’s Disease Based on MR Imaging, Tau PET, and Amyloid PET
por: Jeon, Seun, et al.
Publicado: (2019)

PET Imaging of Astrogliosis and Tau Facilitates Diagnosis of Parkinsonian Syndromes
por: Schönecker, Sonja, et al.
Publicado: (2019)

MicroPET Imaging Assessment of Brain Tau and Amyloid Deposition in 6 × Tg Alzheimer’s Disease Model Mice
por: Kang, ShinWoo, et al.
Publicado: (2022)

Perfusion-Phase [(18)F]THK5351 Tau-PET Imaging as a Surrogate Marker for Neurodegeneration
por: Brendel, Matthias, et al.
Publicado: (2017)

Brain histamine H(1) receptor occupancy after oral administration of desloratadine and loratadine
por: Nakamura, Tadaho, et al.
Publicado: (2019)

Novel PET/SPECT Probes for Imaging of Tau in Alzheimer's Disease
por: Watanabe, Hiroyuki, et al.
Publicado: (2015)

[(18)F]THK-5351 PET imaging in early-stage semantic variant primary progressive aphasia: a report of two cases and a literature review
por: Kobayashi, Ryota, et al.
Publicado: (2018)

Tau PET imaging: present and future directions
por: Saint-Aubert, Laure, et al.
Publicado: (2017)

Stacked binding of a PET ligand to Alzheimer’s tau paired helical filaments
por: Merz, Gregory E., et al.
Publicado: (2023)

Preliminary mechanistic insights of a brain-penetrant microtubule imaging PET ligand in a tau-knockout mouse model
por: Damuka, Naresh, et al.
Publicado: (2022)

Identification of Heterogeneous Subtypes of Mild Cognitive Impairment Using Cluster Analyses Based on PET Imaging of Tau and Astrogliosis
por: Lee, Hyun Jeong, et al.
Publicado: (2021)

Cryo-EM structure of Alzheimer’s disease tau filaments with PET ligand MK-6240
por: Kunach, Peter, et al.
Publicado: (2023)

Cryo-EM Structures of Chronic Traumatic Encephalopathy Tau Filaments with PET Ligand Flortaucipir
por: Shi, Yang, et al.
Publicado: (2023)

PET Imaging of Tau Pathology in Alzheimer’s Disease and Tauopathies
por: James, Olga G., et al.
Publicado: (2015)

Involvement of the Precuneus/Posterior Cingulate Cortex Is Significant for the Development of Alzheimer’s Disease: A PET (THK5351, PiB) and Resting fMRI Study
por: Yokoi, Takamasa, et al.
Publicado: (2018)

Orengedokuto and san'oshashinto improve memory deficits by inhibiting aging-dependent activation of glycogen synthase kinase-3β
por: Fujiwara, Hironori, et al.
Publicado: (2018)

Dual tracer tau PET imaging reveals different molecular targets for (11)C-THK5351 and (11)C-PBB3 in the Alzheimer brain
por: Chiotis, Konstantinos, et al.
Publicado: (2018)

Cryo-EM structures of tau filaments from Alzheimer’s disease with PET ligand APN-1607
por: Shi, Yang, et al.
Publicado: (2021)

Increased retention of tau PET ligand [(18)F]-AV1451 in Alzheimer’s Disease Psychosis
por: Gomar, J. J., et al.
Publicado: (2022)

Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease
por: Leuzy, Antoine, et al.
Publicado: (2019)

Reversal of spatial memory impairment by phosphodiesterase 3 inhibitor cilostazol is associated with reduced neuroinflammation and increased cerebral glucose uptake in aged male mice
por: Yanai, Shuichi, et al.
Publicado: (2022)

Amyloid- and tau-PET imaging in a familial prion kindred
por: Jones, David T., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dfdjsp694nluhvic9mcq9b561g